Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001628280-22-025099

Chief Financial Officer bought 30,000 shares at $1.56 ($46,710)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Levine James E. Chief Financial Officer 2022-09-16 Purchase +30,000 $1.56 $46,710 60,000 D: show line 1 in the form
Open-market purchases · 30,000 sh · avg $1.56 · $46,710
Loading xslF345X03/wf-form4_166359101233703.xml…